Free Cash Flow (Quarterly) Chart

View Free Cash Flow (Quarterly) for TRUMY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow (Quarterly) Chart
Start Trial

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2003. Start Trial.
Date Value
June 30, 2026 349.28M
March 31, 2026 307.79M
December 31, 2025 130.54M
September 30, 2025 328.53M
June 30, 2025 85.48M
March 31, 2025 240.68M
December 31, 2024 198.24M
September 30, 2024 292.83M
June 30, 2024 108.42M
March 31, 2024 209.61M
December 31, 2023 146.05M
September 30, 2023 166.72M
June 30, 2023 -55.86M
March 31, 2023 175.44M
December 31, 2022 -30.96M
September 30, 2022 132.90M
June 30, 2022 58.87M
March 31, 2022 222.19M
December 31, 2021 126.44M
September 30, 2021 161.94M
June 30, 2021 90.98M
March 31, 2021 260.97M
December 31, 2020 131.69M
September 30, 2020 17.85M
June 30, 2020 -45.47M
Date Value
March 31, 2020 149.91M
December 31, 2019 59.94M
September 30, 2019 92.08M
June 30, 2019 9.006M
March 31, 2019 167.03M
December 31, 2018 40.69M
September 30, 2018 130.00M
June 30, 2018 15.88M
March 31, 2018 274.98M
December 31, 2017 132.61M
September 30, 2017 190.97M
June 30, 2017 58.11M
March 31, 2017
December 31, 2016
September 30, 2016
June 30, 2016
March 31, 2016
December 31, 2015
September 30, 2015
June 30, 2015
March 31, 2015
December 31, 2014
September 30, 2014
June 30, 2014
March 31, 2014

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

View Free Cash Flow (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow (Quarterly) Benchmarks

View Free Cash Flow (Quarterly) Benchmarks
Start Trial
Mani, Inc. --
Nipro Corp. --
HOYA Corp. 385.66M
Nakanishi, Inc. --
Abbott Laboratories 1.991B